Prima BioMed Ltd.

Prima BioMed Ltd.

Sector: Commercial Physical And Biological Research Region: Australia

: | ASX: PRR | Nasdaq: PBMD

Similar to: Cerep SA, Medivir AB, Advanced Cell Technology, Inc.

Prima BioMed Ltd. is a biotechnology company, which has focused on developing novel oncology therapies in the field of immunotherapy. The company's core product is CVac, which is vaccine therapy treatment for ovarian cancer patients administered post-surgery and post-chemotherapy to delay the relapse of and control the metastases of the cancer. It operates through two segments, including Cancer Immunotherapy and Other R & D. Prima BioMed as founded in 1987 and is headquartered in Sydney, Australia.

News & Analysis

You may also be interested in: